Squarepoint Ops LLC Has $3.83 Million Holdings in Aspen Aerogels, Inc. (NYSE:ASPN)

Squarepoint Ops LLC lowered its position in Aspen Aerogels, Inc. (NYSE:ASPN) by 4.2% during the second quarter, according to its most recent filing with the SEC. The firm owned 160,665 shares of the construction company’s stock after selling 7,038 shares during the period. Squarepoint Ops LLC owned 0.21% of Aspen Aerogels worth $3,832,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of ASPN. nVerses Capital LLC acquired a new position in Aspen Aerogels in the second quarter valued at $95,000. Banque Cantonale Vaudoise lifted its stake in shares of Aspen Aerogels by 37.5% in the 1st quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock valued at $81,000 after purchasing an additional 1,252 shares during the period. Point72 DIFC Ltd bought a new stake in shares of Aspen Aerogels during the 2nd quarter valued at about $121,000. Public Employees Retirement Association of Colorado acquired a new stake in Aspen Aerogels during the second quarter worth approximately $145,000. Finally, NorthCrest Asset Manangement LLC bought a new stake in Aspen Aerogels in the second quarter worth approximately $217,000. 97.64% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the sale, the chief financial officer now directly owns 20,790 shares of the company’s stock, valued at $626,610.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the transaction, the chief financial officer now owns 20,790 shares in the company, valued at $626,610.60. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Donald R. Young sold 63,355 shares of the firm’s stock in a transaction dated Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the sale, the chief executive officer now owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. The disclosure for this sale can be found here. Insiders own 4.30% of the company’s stock.

Analysts Set New Price Targets

ASPN has been the topic of a number of research analyst reports. Roth Mkm restated a “buy” rating and set a $36.00 price target on shares of Aspen Aerogels in a report on Wednesday, August 21st. Benchmark reaffirmed a “buy” rating and issued a $14.00 price target on shares of Aspen Aerogels in a research note on Thursday, August 8th. B. Riley raised shares of Aspen Aerogels to a “strong-buy” rating in a research report on Tuesday, June 25th. TD Cowen boosted their target price on Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a research report on Tuesday, August 20th. Finally, Barclays initiated coverage on Aspen Aerogels in a report on Tuesday, August 6th. They issued an “overweight” rating and a $27.00 price target on the stock. One research analyst has rated the stock with a sell rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Aspen Aerogels has a consensus rating of “Moderate Buy” and a consensus target price of $29.70.

Aspen Aerogels Trading Down 5.9 %

Shares of Aspen Aerogels stock opened at $26.06 on Wednesday. The company has a market capitalization of $1.98 billion, a P/E ratio of -59.23 and a beta of 2.16. The stock has a fifty day simple moving average of $25.20 and a 200 day simple moving average of $23.73. Aspen Aerogels, Inc. has a 12-month low of $6.62 and a 12-month high of $33.15. The company has a current ratio of 3.46, a quick ratio of 2.82 and a debt-to-equity ratio of 0.23.

Aspen Aerogels (NYSE:ASPN) last announced its earnings results on Wednesday, August 7th. The construction company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.05 by $0.16. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The company had revenue of $117.80 million during the quarter, compared to the consensus estimate of $101.99 million. During the same quarter in the prior year, the company posted ($0.22) earnings per share. The firm’s revenue for the quarter was up 144.4% on a year-over-year basis. On average, sell-side analysts anticipate that Aspen Aerogels, Inc. will post 0.21 earnings per share for the current fiscal year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.